1939年白皮书Barnett Janner, Baron Janner(英语:Barnett Janner, Baron Janner) Pending the remitting of this question to the United Nations, are we to understand that the
尤斯泰金單抗IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised